Meiji Seika Pharma Co., Ltd.
42 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 5 name spellings.
Previously recorded as Meiji Seika Kaisha, Ltd. (to 2011)
11
Ending by 2030
Dec 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 22, 2027The maintenance fee for Processes for preparing a diazabicyclooctane compound (US 11,731,971) comes due Feb 22, 2027. Unpaid by Aug 23, 2027, it lapses early.
- 1 fee due May 10, 2027The maintenance fee for Beta-lactamase inhibitor and process for preparing the same (US 9,181,250) comes due May 10, 2027. Unpaid by Nov 10, 2027, it lapses early.
- 1 fee due Aug 11, 2027The maintenance fee for Processes for preparing a diazabicyclooctane compound (US 10,556,905) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
- 1 fee due Sep 30, 2027The maintenance fee for Processes for producing diazabicyclooctane compounds (US 10,604,522) comes due Sep 30, 2027. Unpaid by Mar 31, 2028, it lapses early.
- 1 fee due Oct 14, 2027The maintenance fee for Effective aminoglycoside antibiotic for multidrug-resistant bacteria (US 10,617,704) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Sep 29 US 12,747,247 Method for Producing Benzoxazole Derivative Having Bicyclic Piperazine Ring or Salt Thereof, and Method for Producing Material Thereof
- 1 term has ended since Aug 23, 2026
- Nov 10 US 7,893,254 Process for Production of 3-Alkenylcephem Compounds · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,257,955 | Endoglucanase Ppce and Cellulase Preparation Containing the Same In force · High confidence | In force | High confidence | |
| US 8,227,430 | Injectable, Injection Solution, and Injection Kit Preparation In force · High confidence | In force | High confidence | |
| US 8,383,392 | Transformant and Method for Production of Non-Natural Antibiotic In force · High confidence | In force | High confidence | |
| US 8,440,400 | Process for Amplifying DNA in Cells In force · High confidence | In force | High confidence | |
| US 8,569,033 | Surfactant Tolerant Cellulase and Method for Modification Thereof In force · High confidence | In force | High confidence | |
| US 8,975,053 | Thermostable Catalase In force · High confidence | In force | High confidence | |
| US 8,697,409 | Ketoreductase mutant In force · USPTO record | In force | USPTO record | |
| US 10,774,318 | Novel Cellulase Gene In force · High confidence | In force | High confidence | |
| US 10,125,355 | Protein having B-glucosidase activity and uses thereof In force · USPTO record | In force | USPTO record | |
| US 8,975,057 | Novel Protein Having B-Glucosidase Activity and Uses Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 37: 42 patents in force now held by others · 67 lapsed for an unpaid fee · 40 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 4 abandoned · 25 no status recorded